Surgery – Truss – Perineal
Patent
1977-08-23
1980-03-04
Michell, Robert W.
Surgery
Truss
Perineal
128216, 424 94, A61M 500
Patent
active
041911768
ABSTRACT:
An enzymatic intralenticular cataract treatment for removal of nuclear cortical and subcapsular regions of the cataractous lens through enzymatic digestion thereof which comprises introduction of a concentrated solution of a trypsin enzyme into the nuclear and cortical regions of a cataractous lens, and after enzymatic digestion removing the liquefied cataractous material. The procedure allows subsequent removal of the nuclear, cortical and subcapsular portions of a cataractous lens through a very tiny incision in the eye and lens capsule, leaving all other structures within the eye intact. Bovine and porcine trypsins are preferred.
REFERENCES:
patent: 3320131 (1967-05-01), Smith
patent: 3589363 (1971-06-01), Banko
patent: 3683069 (1972-08-01), Hooreman
patent: 4078564 (1978-03-01), Spina et al.
Preparation and Properties of Water-Insoluble Derivatives of Trypsin-Atha Ban-Eli & Epraim Katchalaski, Journal of Biol. Research Chemistry, vol. No. 5, May 1963, pp. 1690-1698.
Spina Joseph
Weibel Michael K.
Juten Milford
Michell Robert W.
Novo Laboratories, Inc.
LandOfFree
Intralenticular cataract surgery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intralenticular cataract surgery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intralenticular cataract surgery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2035393